Stay updated on Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new site revision v3.4.3 was added and the previous revision v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-07T05:56:15.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page shows a new revision label (v3.4.2) replacing the previous (v3.4.1). This appears to be a cosmetic version update.
    Difference
    0.0%
    Check dated 2026-02-13T12:38:37.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now displayed, replacing the previous v3.4.0; no substantive content or functionality changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T17:20:24.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The label 'Last Update Posted (Estimated)' in the Study Record Dates section has been replaced with 'Last Update Posted'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-22T06:20:50.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4, a minor version bump with no changes to visible content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:43:47.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations section updated to reflect changes in trial sites, adding and removing site entries across the U.S. and Canada (California, Illinois, Indiana, Michigan, Pennsylvania, Alberta, Ontario). The revision tag shows v3.3.3.
    Difference
    0.7%
    Check dated 2025-12-24T14:49:53.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.